Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biodesix Inc (NQ: BDSX ) 1.710 +0.010 (+0.59%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Biodesix Inc < Previous 1 2 3 4 Next > Biodesix to Present at Two Investor Conferences in September September 05, 2024 From Biodesix, Inc. Via Business Wire Biodesix Announces Second Quarter 2024 Results and Highlights August 07, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference August 06, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024 July 24, 2024 From Biodesix, Inc. Via Business Wire Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces” June 18, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Participate in Two Investor Conferences in June May 28, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting May 21, 2024 From Biodesix, Inc. Via Business Wire Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management May 08, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference May 07, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 April 24, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting April 09, 2024 From Biodesix, Inc. Via Business Wire Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement April 05, 2024 From Biodesix, Inc. Via Business Wire Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center March 25, 2024 From Biodesix, Inc. Via Business Wire Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights March 01, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference February 26, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 February 16, 2024 From Biodesix, Inc. Via Business Wire Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method November 14, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Participate in Two Upcoming Investor Conferences in November November 09, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Third Quarter 2023 Results and Highlights November 07, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023 October 24, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting October 03, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer September 07, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Participate in Two Upcoming Investor Conferences in September September 05, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer August 22, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Second Quarter 2023 Results and Highlights August 07, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference August 01, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023 July 24, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules July 12, 2023 From Biodesix, Inc. Via Business Wire Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services July 06, 2023 From Biodesix, Inc. Via Business Wire Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier June 27, 2023 From Biodesix, Inc. Via Business Wire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.